EyeYon Medical develops and brings to market exclusive medical ophthalmic devices, which offer relief to unmet clinical need for millions of patients. Its innovative technologies are proven in clinical studies.
EyeYon’s first product, Hyper-CL™, a therapeutic contact lens for treating corneal edema, has received the CE Mark and FDA 510(k) clearance, and is approved for marketing in Europe, the USA and additional territories.
EyeYon’s future product, the EndoArt® is an artificial endothelial layer that cures corneal edema using an implant made of silicon film attached to the posterior corneal surface. The EndoArt® is in pre-clinical stage and has demonstrated promising results in animal trials.
Ofer is an inventor, entrepreneur and researcher, owner of several patents in the eye field. Ofer specialized in corneal and cataract surgery. Ofer is a senior cornea and cataract surgeon at Assuta Hashalom Medical Center.
Nahum is an entrepreneur who specializes in leading medical device projects from idea to a successful products. Nahum holds a B.Sc in Bio-medical Engineering and an MBA, both from Tel Aviv University.
Malca has over two decades of experience in the fields of regulatory affairs, preclinical research and clinical trials of medical devices and biotechnology, with an extensive experience working with ophthalmology products. Malca holds a Ph.D in Biology with highest distinction from Bar-Ilan University.
Dimitry has more than ten years’ experience in the medical device industry, and has expertise in product development from device concept to marketplace. Dimitry holds a master's degree in Electro-Optical Engineering from Ben-Gurion University.
Dar has extensive experience in constructing experimental setups, designing computational models and carrying out laboratorial pre-clinical and clinical experiments.
He has substantial background in biomechanics and biofluids.
Dar holds a Ph.D in Biomedical Engineering from Tel Aviv University.
Michal holds an LL.B, B.A (Econ) and an MBA (Marketing, Strategy & Entrepreneurship). She has over 6 years of sales and marketing experience in the medical device industry, at Ethicon J&J and various startup companies.
Hagit has more than twelve years of experience in the medical device industry, and has expertise in the fields of project management, quality assurance and compliance. Hagit holds M.Sc in Biotechnology from The Hebrew University, Jerusalem.
Mali is a certified bookkeeper with over 6 years of office management, operation and bookkeeping experience with medical device companies in the commercial stage.
Doyle is Director of Corneal Disease & Research at Woolfson Eye Institute. His career spans more than 30 years. Doyle chaired the Ophthalmic Devices Panel, an advisory group to the FDA, for three years and served as a member for ten. Doyle holds a B.Sc, MD, and PhD, all from Duke University.
Dr. Levy OD, MSc. has a long and distinguished career in the field of ophthalmology, a wide industry knowledge, skills and experience. He serves as a Clinical Professor in the Department of Ophthalmology at the University of Rochester's School of Medicine, and held several leading positions at Aerie Pharmaceuticals, Inc., Nexis Vision and Bausch + Lomb.
A founding partner and coordinator of the cornea, cataract and refractive surgery department of the IMO. The president of the European Society of Cornea and Ocular Surface Disease (EuCornea) and a member of the Editorial Board of Eurotimes Journal, Studium Ophthalmologicum and the Journal of Cataract and Refractive Surgery, and co-editor of the Consultation Section, EyeWorld Magazine since 2004.
Arie is a senior ophthalmic surgeon at the Kaplan Medical Center. Arie specialized in corneal surgery at the University of Toronto. He is former chairperson of the Israel Society of Cataract Surgeons and a guest lecturer in Israeli and international conferences. Arie is currently completing Ph.D studies for specialist MDs at the Weizmann Institute of Science, conducting research on corneal diseases.
Buddy is a professor of chemical engineering and bioengineering. He is also director of the Research Center for Biomaterials at the University of Washington. An expert in specially designed materials (biomaterials) used in medical devices and implants, drug delivery to the eye and to the brain, micronutrient analysis for global health applications, and surface analysis for biomedical problems.
Deputy director of the Department of Ophthalmology, Peking University, Third Hospital, Professor, Chief Physician, doctoral tutor, director of cornea ocular surface disease department, eye bank director, committee member of Chinese Ophthalmological Society Corneal Disease Group.
Claes is clinical and research director for Orasis Pharma and Fepasaet Group. A visiting professor at Ben Gurion University, Israel and at Moscow State University branch MNTK. Claes is also the author of several scientific articles, and also contributed chapters to many books and is co-author, with Prof. Sudhir Patel, of Basics in Refractive Surgery.